Triglyceride-Glucose Index Combined with DAS28-ESR Predicts Cardiovascular Disease Risk in Patients with Rheumatoid Arthritis: A national multicenter cohort study
This national multicenter cohort study demonstrates that combining the triglyceride-glucose (TyG) index with DAS28-ESR scores significantly enhances the prediction of cardiovascular disease risk in rheumatoid arthritis patients by revealing a synergistic interaction between systemic inflammation and metabolic dysfunction, as well as the prognostic impact of their longitudinal trajectories.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Rheumatoid arthritis is a condition where the body's immune system mistakenly attacks its own joints, causing pain, swelling, and stiffness. For decades, doctors have known that people with this disease face a much higher risk of developing heart disease and stroke than the general population. This is not surprising, as chronic inflammation—the same fire that damages the joints—can also damage blood vessels. However, treating the joint inflammation alone has not always been enough to protect the heart. Scientists have long suspected that another hidden factor might be at play: the body's ability to process sugar and fat. When the body struggles to manage these fuels, it creates a state of metabolic stress that can further harm the cardiovascular system. The question remains whether the combination of active joint inflammation and this metabolic stress creates a danger greater than the sum of its parts, and if the way these factors change over time can predict who is most at risk.
A large team of researchers from the China Academy of Chinese Medical Sciences set out to answer this question by following nearly 5,000 patients with rheumatoid arthritis who did not have heart disease at the start of the study. They tracked these individuals for a median of six years, looking for new cases of heart disease or stroke. To understand the risks, the researchers measured two specific things for every patient. First, they assessed the level of joint inflammation using a standard score called DAS28-ESR, which combines the number of tender and swollen joints with a blood test for inflammation. Second, they calculated an index known as TyG, which uses levels of triglycerides and glucose in the blood to estimate how well the body is handling sugar and fat. By grouping patients based on whether they had high or low levels of inflammation and high or low levels of metabolic stress, the team could see how these factors worked together.
The results revealed a stark reality for patients who carried both burdens. Those who had high inflammation and high metabolic stress at the beginning of the study were nearly ten times more likely to develop heart disease during the follow-up period compared to patients who had low levels of both. The risk was not simply additive; the two factors seemed to amplify each other. The researchers found that when high inflammation and poor metabolic health occurred together, they created a synergistic effect, meaning the combined danger was significantly greater than if either factor existed alone. In fact, the study estimated that about 38 percent of the heart disease events in this high-risk group were directly caused by the interaction between the two conditions. This suggests that the body's struggle to manage sugar and fat, when paired with an active immune attack, creates a perfect storm for blood vessel damage.
The study also looked at how these conditions changed over time, offering a dynamic view of patient health. The researchers discovered that patients who managed to lower their joint inflammation through treatment but still maintained high metabolic stress did not escape danger. Even when the joints were quiet, the lingering metabolic issues continued to pose a significant cardiovascular threat. Conversely, the patients who remained in a state of high inflammation and high metabolic stress throughout the entire six-year period faced the highest cumulative risk of all. This finding challenges the idea that controlling joint pain is the only goal. It indicates that even if a patient feels better in their joints, they may still be walking a tightrope if their blood sugar and fat levels remain uncontrolled.
The data showed that the relationship between these factors and heart risk was not a straight line. The risk of heart disease rose sharply once inflammation scores crossed a certain threshold, and the metabolic index showed a complex curve where risk peaked at specific levels before shifting. These patterns suggest that there are critical tipping points in the body's response to these stressors. The study concludes that to truly protect the hearts of people with rheumatoid arthritis, medical care must move beyond a single focus on calming the immune system. Instead, a dual-track approach is needed, where doctors actively manage both the joint inflammation and the metabolic health of the patient simultaneously. By addressing both the fire in the joints and the stress in the metabolism, clinicians may be able to significantly reduce the burden of heart disease in this vulnerable population.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.